Purdue Frederick pays out Texas portion of settlement in pain-killer case - St. Louis Business Journal:

tenamup.wordpress.com
million from and its subsidiary as part of a national settlement with stat eMedicaid programs. The $1.6 million payment resolves Medicaid fraud investigationds undertaken by Texas Attorney General Greg Abbott related tothe company's product OxyContin. Abbott's office claimed that Purdur misrepresented addictive properties associated withits drug. Purdu e marketed OxyContin to Medicaid, physicians and patients as beingvless addictive, less susceptible to abusde and less likely to causes withdrawal problems than other pain medications, according to the Texas received a portionh of the funds from the company'as $130 million global settlement with state Medicaidd programs.
Purdue has since taken steps to ensure that employees properly promotreOxyContin tablets, including providing clear indicationa for its use in patients. "Thids agreement ensures that physicians and patients are fullyh informed about the risks associatefdwith OxyContin," Abbott says. "Whej Medicaid dollars are spent on falsel representedpharmaceutical products, it is critical that the taxpayerws are reimbursed for their Purdue is a Stamford, Conn.-based pharmaceutical company specializin in pain treatment.
The companu develops both prescriptionand over-the-countet drugs and continues to market